References
- Damitz R, Chauhan A. Parenteral emulsions and liposomes to treat drug overdose. Adv Druv Deliv Reviews. 2015;90:12–23.
- Forster V, LeRoux JC. Nano-antidotes for drug overdose and poisoning. Sci Translational Med. 2015;290:ps14.
- Gomez Outes A, Suarez-Gea M, Lecumberri R, et al. Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives. Eur J Haematol. 2015;95:389–404.
- Chemaxon [Internet]. Budapest: Chemaxon. [cited 2015 Dec 31]. Available from: http://www.chemicalize.org/structure/#!mol=dabigatran&source=fp
- Stangier J, Clemens A. Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor. Clin Appl Thromb Hemost. 2009;15:9S–16S.
- U.S. Food and Drug Administration [Internet]. Silver Springs: U.S. Food and Drug Administration. [cited 2015 Dec 31]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm467300.htm
- Forster V, Signorell RD, Roveri M, et al. Liposome-supported peritoneal dialysis for detoxification of drugs and endogenous metabolites. Sci Translational Med. 2014;258:258ra141
- Forster V, Luciani P, Rous L. JC, Treatment of calcium channel blocker-induced cardiotoxicity with drug scavenging liposomes. Biomaterials. 2012;42:3577–3585.
- Aniara [Internet]. West Chester: Aniara Diagnostica. Available from: http://www.aniara.com/pdf/INS-ACK011K-RUO.pdf
- Blum J, Carreiro S, Hack J. Intravenous lipid emulsion does not reverse dabigatran-induced anticoagulation in a rat model. Acad Emerg Med Emergency. 2013;20:1022–1025.
- Mayer DL, Reamer J, Bally MB. Intravenous pretreatment with empty pH gradient liposomes alters the pharmacokinetics and toxicity of doxorubicin through in vivo active drug encapsulation. J Pharma Sci. 1999;88:96–102.
- Aniara [Internet]. West Chester: Aniara Diagnostica. [cited 2015 Dec 31] Available from: http://www.aniara.com/pdf/SS-ANIARA-HowtotestforDabigatran.pdf
- Zucker D, Marcus D, Barenholz Y, et al. Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties. J Control Release. 2009;139:73–80.